Market Overview
Laboratory robotics comprises a broad spectrum of automated hardware and software solutions designed to reduce manual labor, minimize human error, and increase throughput in scientific and diagnostic settings. The market spans benchtop liquid handling systems, high-throughput screening robots, automated storage and retrieval systems, and laboratory information management software. Applications range from drug discovery and genomics to clinical diagnostics and materials science.
- •Estimated market value of $61.9 billion in 2025
- •Projected CAGR of 15.07% over the forecast period
- •Encompasses hardware, software, and integrated laboratory automation platforms
Growth Drivers
The pharmaceutical and biotechnology industries continue to invest heavily in research and development, creating sustained demand for high-throughput screening and automated workflows that can process thousands of samples daily. Laboratories face ongoing pressure to do more with fewer personnel, and robotic systems help address chronic staffing shortages while improving consistency and data quality. Additionally, advances in artificial intelligence and machine learning are enabling smarter, adaptive laboratory robots that can optimize experimental protocols in real time.
- •Growing R&D investment in drug discovery and personalized medicine
- •Labor shortages and rising operational costs driving automation adoption
- •AI and ML integration enabling more intelligent and adaptive lab workflows
Segmentation and Regional Analysis
The market is commonly segmented by product type, including robotic arms and workcells, automated liquid handling systems, plate handling and storage systems, and laboratory software platforms. End-use segments include pharmaceutical and biotechnology companies, clinical and hospital laboratories, academic and research institutions, and contract research organizations. Geographically, North America currently leads in market share due to strong pharmaceutical R&D spending and advanced healthcare infrastructure, while the Asia-Pacific region is expected to see the fastest growth as laboratory modernization accelerates.
- •North America leads in adoption, supported by strong pharma R&D budgets
- •Asia-Pacific projected as the fastest-growing regional market
- •Key end-user segments include pharma/biotech firms, hospital labs, and CROs
Trends and Outlook
What are the recent trends and outlook?
Looking ahead, the market is expected to benefit from the convergence of robotics, artificial intelligence, and cloud-based laboratory informatics, enabling increasingly autonomous and interconnected laboratory ecosystems. The growing emphasis on personalized medicine and genomic research is likely to drive demand for flexible automation platforms capable of handling complex, variable workflows. As cost pressures mount and the need for rapid, reliable scientific results intensifies, laboratory robotics is poised to become an increasingly standard component of modern scientific infrastructure over the coming decade.
- •Integration of AI and cloud informatics is shaping the next generation of autonomous laboratories
- •Personalized medicine and genomics research are creating demand for flexible, adaptive automation
- •Long-term outlook remains strong as robotics becomes standard in scientific and diagnostic workflows
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.